75F40125F19005↗
Kaiva Strategies, LLC received this contract from Fda Office of Acq Grant Svcs, Food and Drug Administration: $519.9K obligated so far for support- professional: other. It runs to 2027-04-09, or to 2029-04-09 if every option is exercised.
Key facts · data as of Oct 23, 2026
- Recipient
- Kaiva Strategies, LLC
- Awarding agency
- Food and Drug Administration (Department of Health and Human Services)
- Contracting office
- Fda Office of Acq Grant Svcs (75F401)
- Obligated to date
- $519.9K
- Potential value
- $1.42M
- Ends
- 2027-04-09
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 23, 2026.
Cite this page: SpendQuery, Award 75F40125F19005, data as of Oct 23, 2026, https://spendquery.com/award?id=CONT_AWD_75F40125F19005_7524_75F40123D00021_7524
Kaiva Strategies, LLC: all federal awards · Department of Health and Human Services: spending · Fda Office of Acq Grant Svcs: what it buys · The follow-on: recompete brief
BASE PERIOD AND THREE (3) OPTION PERIODS, LABOR HOUR (LH) TYPE TASK ORDER TO PROCURE REGULATORY SUPPORT IN THE RESEARCH AND DOCUMENTATION OF DATA AND INFORMATION TO SUPPORT THE REVIEW OF ABBREVIATED NEW DRUG APPLICATIONS FOR THE FDA'S CENTER FOR
Up for re-bid: ends 2027-04-09. Recompete brief → · Contractor-Hosted Fully Integrated Records Facility (FIRF) IDIQ ↗
What it is
- Product or service
- Support- Professional: Other (PSC R499)
- Industry
- Administrative Management and General Management Consulting Services (NAICS 541611)
- Contracting office
- Fda Office of Acq Grant Svcs (75F401)
- Competition
- Full and open after exclusion of sources
- Pricing
- Labor hours
- How it was bought
- Single-award IDIQ · under 75F40123D00021
- Where the work is
- Washington, UT · district UT-02
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
Every action
3 actions since 2025-08-04. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-03-18 | P00002 | Supplemental agreement (work within scope) | $351.8K | REVISE OP1, OP2, OP3 AND EXERCISE OP1. BASE PERIOD AND THREE (3) OPTION PERIODS, LABOR HOUR (LH) TYPE TASK ORDER TO PROCURE REGULATORY SUPPORT IN THE RESEARCH AND DOCUMENTATION OF DATA AND INFORMATION TO SUPPORT THE REVIEW OF ABBREVIATED NEW DRUG APP |
| 2025-12-10 | P00001 | Supplemental agreement (work within scope) | $0 | NO COST TIME EXTENSION (ALL PERIODS). BASE PERIOD AND THREE (3) OPTION PERIODS, LABOR HOUR (LH) TYPE TASK ORDER TO PROCURE REGULATORY SUPPORT IN THE RESEARCH AND DOCUMENTATION OF DATA AND INFORMATION TO SUPPORT THE REVIEW OF ABBREVIATED NEW DRUG APP |
| 2025-08-04 | 0 | $168.0K | BASE PERIOD AND THREE (3) OPTION PERIODS, LABOR HOUR (LH) TYPE TASK ORDER TO PROCURE REGULATORY SUPPORT IN THE RESEARCH AND DOCUMENTATION OF DATA AND INFORMATION TO SUPPORT THE REVIEW OF ABBREVIATED NEW DRUG APPLICATIONS FOR THE FDA'S CENTER FOR |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-23). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗